Stockscreener 앱 받기
0.179
17.70%
-0.0385
전일 마감가:
$0.2175
열려 있는:
$0.2125
하루 거래량:
993.99K
Relative Volume:
0.39
시가총액:
$3.67M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-10.50%
1개월 성능:
-69.71%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.1638
$0.2229
1주일 범위
$0.1638
$0.3229
52주 변동 폭
$0.1638
$1.09
Ping An Biomedical Co Ltd Stock (PASW) Company Profile
PASW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PASW
Ping An Biomedical Co Ltd
|
0.179 | 4.46M | 0 | 0 | 0 | 0.00 |
|
AIN
Albany International Corp
|
57.85 | 1.68B | 1.27B | 100.39M | 116.84M | 3.20 |
|
UFI
Unifi Inc
|
4.01 | 72.16M | 583.56M | -53.59M | -18.48M | -2.97 |
|
CULP
Culp Inc
|
3.87 | 48.25M | 237.23M | -13.64M | -6.50M | -1.10 |
Ping An Biomedical Co Ltd 주식(PASW)의 최신 뉴스
FLYEXCLUSIVE INC. (FLYX) Stock, Price, News, Quotes, Forecast and Insights - MSN
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session - Benzinga
11 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Heritage Global Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday? - Chartmill
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session - Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session - Benzinga
Trading Activity Highlights: Nasdaq & NYSE Leaders on January 12, 2026News and Statistics - IndexBox
Ping An Biomedical Secures Strategic Investment from Leading Chinese Tech and VC Executives to Accelerate Biopharma Growth - TipRanks
Ping An Biomedical Shares Surge After Securing Strategic Investment - Nasdaq
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga
PASW Stock Price, Forecast & Analysis | PING AN BIOMEDICAL CO LTD (NASDAQ:PASW) - Chartmill
Crypto: PASW Warning: Key Support Level Being Tested Right Now - InteractiveCrypto
United States shares higher at close of trade; Dow Jones Industrial Average up 0.48% By Investing.com - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com
United States shares higher at close of trade; Dow Jones Industrial Average up 0.48% - Investing.com India
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session - Benzinga
Future Biotechnology Group Co., Ltd announced that it expects to receive $90 million in funding from Ping An Biomedical Co., Ltd. - marketscreener.com
Ping An Biomedical Co., Ltd. announced a financing transaction - MarketScreener
Ping An Biomedical (PASW) Stock: Gains Strategic Investors While Addressing Nasdaq Compliance - parameter.io
11 Consumer Discretionary Stocks Moving In Friday's Intraday Session - Benzinga
Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com - Investing.com Australia
Remedy’s Nutrition® Unveils Hair Tissue Mineral Analysis: A Revolutionary Personalized Approach to Nutritional Wellness - The Manila Times
Ping An Bio to invest $90 million in Future Biotechnology Group By Investing.com - Investing.com South Africa
Shopley Announces Steve Levely as Chief Executive Officer - The Manila Times
Cabot Corporation to Announce First Quarter Fiscal 2026 Operating Results - The Manila Times
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - The Manila Times
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry - The Manila Times
Sienna Announces Fourth Quarter 2025 Results Release Date and Conference Call - The Manila Times
Greenstone Files Early Warning Report for Marimaca Copper Corp. - The Manila Times
ACTG Launches IPACE-HIV to Study Frailty Intervention - The Manila Times
ProMach Acquires American Holt, DMA Solution, and Pride Engineering from Arcline - The Manila Times
Ping An Biomedical secures investment from three notable investors By Investing.com - Investing.com Nigeria
Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026 - The Manila Times
uniQure Announces Type A Meeting Scheduled with FDA - The Manila Times
La Rosa Holdings Corp. Announces Closing of Initial Funding Under $250 Million Note Facility as Part of $1.25 Billion AI Infrastructure Program - The Manila Times
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation - The Manila Times
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference - The Manila Times
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker 'LONA” - The Manila Times
H&R Block Tax Pro Review Free for New Clients with Purchase of DIY Products - The Manila Times
Nobel Announces Non-Brokered Private Placement Offering - The Manila Times
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - The Manila Times
Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, January 27, 2026 - The Manila Times
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger - The Manila Times
Mutuum Finance's Phase 7 is Surging as MUTM Growth Exceeds 300% Growth Since 2025 - The Manila Times
Aurora Mobile Partners with Xiaoe to Enhance Interaction Efficiency and Support Sustainable Growth in Private Domain Ecosystems - The Manila Times
VR Upsizes Brokered Private Placement Led by Centurion One Capital to $1,500,000 - The Manila Times
Predis.ai Announces Launch of New State-of-the-Art (SOTA) AI Models for Ad Videos - The Manila Times
Ping An Biomedical Co Ltd (PASW) 재무 분석
Ping An Biomedical Co Ltd (PASW)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.57%
1.14%
자본화:
|
볼륨(24시간):